azilect

Generic: rasagiline mesylate

Labeler: teva neuroscience, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name azilect
Generic Name rasagiline mesylate
Labeler teva neuroscience, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

rasagiline mesylate .5 mg/1

Manufacturer
Teva Neuroscience, Inc.

Identifiers & Regulatory

Product NDC 68546-142
Product ID 68546-142_e90d2f30-97b1-4c76-8038-df259889e3b5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA021641
Listing Expiration 2026-12-31
Marketing Start 2006-07-10

Pharmacologic Class

Classes
monoamine oxidase inhibitor [epc] monoamine oxidase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68546142
Hyphenated Format 68546-142

Supplemental Identifiers

RxCUI
608328 636664 637185 637218
UNII
LH8C2JI290

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name azilect (source: ndc)
Generic Name rasagiline mesylate (source: ndc)
Application Number NDA021641 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • .5 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (68546-142-56)
source: ndc

Packages (1)

Ingredients (1)

rasagiline mesylate (.5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "e90d2f30-97b1-4c76-8038-df259889e3b5", "openfda": {"unii": ["LH8C2JI290"], "rxcui": ["608328", "636664", "637185", "637218"], "spl_set_id": ["a40d0e73-3f9f-4b01-979d-402c9cdaeb60"], "manufacturer_name": ["Teva Neuroscience, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (68546-142-56)", "package_ndc": "68546-142-56", "marketing_start_date": "20060710"}], "brand_name": "Azilect", "product_id": "68546-142_e90d2f30-97b1-4c76-8038-df259889e3b5", "dosage_form": "TABLET", "pharm_class": ["Monoamine Oxidase Inhibitor [EPC]", "Monoamine Oxidase Inhibitors [MoA]"], "product_ndc": "68546-142", "generic_name": "Rasagiline mesylate", "labeler_name": "Teva Neuroscience, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azilect", "active_ingredients": [{"name": "RASAGILINE MESYLATE", "strength": ".5 mg/1"}], "application_number": "NDA021641", "marketing_category": "NDA", "marketing_start_date": "20060710", "listing_expiration_date": "20261231"}